AzTrials
AzTrials

LaparoscopyNCT04368611

Emergency Laparoscopic Cholecystectomy With Low Pressure Pneumo-peritoneum in Cardiopulmonary Risk Patients: Fundus First Cholecystectomy VS Calot First Cholecystectomy .

A study testing start with fundus and calot first dissection in people with Laparoscopy and Biliary Disease, run by Zagazig University at 2 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Introduction: Laparoscopic cholecystectomy is the usual approach in dealing with cholithiasis that greatly replace open approach even in acute emergency gall bladder diseases. Laparoscopic approach has great advantages than open approach but the biliary injuries are higher in laparoscopic approach than open approach. Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
Laparoscopy, Biliary Disease
What is being tested?
start with fundus and calot first dissection
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
2 sitesEgypt
Study dates
1 Mar 2015to 1 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age: any age.
  • Sex: Male and Non pregnant female.
  • Patients with cardiopulmonary diseases.
  • Patients who diagnose acute cholecystitis not improving on medical treatment for 48 hours.
  • Patients with biliary colic, mucocele of gall bladder and pyocele of gall bladder.
  • American Society of Anesthesiologist's (ASA) score: grade I, II, III.

Who cannot join

  • ASA grade IV
  • Patients refuse surgery.
  • Documented Liver disease.
  • Previous percutaneous cholecystostomy
  • Cases not tolerated CO2 insufflation from the start.

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • Tamer Alsaied Alnaimy

    Zagazig, Sharqia Province, 055

  • Tamer Alsaied Alnaimy

    Zagazig, Sharqia Province, 1234

Other trials in Egypt

About this study

Official title: Emergency Laparoscopic Cholecystectomy With Low Pressure Pneumo-peritoneum in Cardiopulmonary Risk Patients: Fundus First Cholecystectomy VS Calot First Cholecystectomy .Randomized Controlled Trials.

Introduction:

Laparoscopic cholecystectomy is the usual approach in dealing with cholithiasis that greatly replace open approach even in acute emergency gall bladder diseases. Laparoscopic approach has great advantages than open approach but the biliary injuries are higher in laparoscopic approach than open approach. Laparoscopic approach is condemned for many years in cardiopulmonary risk patients because of its adverse impacts on cardiopulmonary systems. Performing laparoscopic cholecystectomy with low pressure pneumoperitoneum may be effective in treatment of acute gall bladder disease but with fundus first approach than classical Calot first approach.

Read more

Aim: compare between initial Fundus first cholecystectomy followed by Calot dissection VS Calot only cholecystectomy in Emergency laparoscopic cholecystectomy with low pressure pneumo-peritoneum in cardiopulmonary risk patients as regard intraoperative data and postoperative complications.

Patients and methods:

This study prospective randomized controlled study was conducted on 470 cases with acute cholecystitis, biliary colic, mucocele and pyocele of gall bladder in emergency general surgery department. Patients were divided into 2 groups, Group A: fundus first group (235cases) and Group B (235cases): classical Calot first approach.

Read the detailed description
  1. INTRODUCTION Introduction of laparoscopy in management of cholithiasis gave a great push to dealing with this disease. The advancement of laparoscopic cholecystectomy had greatly evolved in the last years making laparoscopic cholecystectomy is the commonest operation performed within field of gastrointestinal tract surgery and almost replaced open cholecystectomy.[1] [2] After introduction of laparoscopic cholecystectomy, many advantages the patients gained over open cholecystectomy as small operative wounds with minimal postoperative pain and infection and hence rapid discharge from hospital. Other advantages are better cosmosis, earlier resumption of oral feeding and rapid restoration of daily activity and work. [3] Although laparoscopic cholecystectomy had many advantages over open approach yet, many disadvantages emerged after the wide spread use of laparoscopic cholecystectomy as higher incidence of bile duct injuries that may reach 0.3-0.8% that may increase in acute emergent cases. This is a grave problem that may cause mortality to the patients. [4]Strasberg gave us the best solution up till now and the way to avoid injury to biliary tract. [5].Other complications the patients may face after laparoscopic cholecystectomy are organ injury; vascular injury and obstructive jaundice from missed stone in common bile duct during the operation. [6] About 30% of patients undergo laparoscopic cholecystectomy are elderly patients with cardiopulmonary risks [7] Co2 insufflation into the peritoneal cavity exerts bad effects on cardiac and respiratory systems and may worsen the condition of cardio-pulmonary risk patients. Pneumo-peritoneum with CO2 causes splintage of the diaphragm, hypercarbia with arrhythmias, compression of main abdominal vasculature (Inferior Vena Cava and abdominal aorta) and stretch of the peritoneal cavity with consequent parasympathetic irritation causing baradycardia.[8][9][10][11][12]. Head up position during laparoscopic cholecystectomy exerts good effect on lung but bad effects on heart as it decreases venous return and hence cardiac output. Also, the head up position increases adrenaline level in the blood that lead to vasoconstriction of blood vessels that increase peripheral resistance and decrease cardiac output and increases load on myocardium.[13][14] [15] No randomized studies have compared fundus first laparoscopic cholecystectomy with low pressure pneumoperitoneum with Calot first dissection cholecystectomy in cardiopulmonary risk patients with urgent laparoscopic cholecystectomy. The aim of this study was to evaluate and compare the outcome of urgent LC using either fundus first approach or Calot classic approach in cardiopulmonary risk patients as regard morbidity and mortality.
  2. THE AIM OF THE WORK The aim of this study was to evaluate and compare the outcome of urgent laparoscopic cholecystectomy under low pressure Pneumo-peritoneum using either fundus first approach and Calot classic approach in cardiopulmonary risk patients as regard morbidity and mortality.
  3. Patients and methods Study design: Prospective Randomized controlled clinical study. Study place: our study was conducted in the surgical emergency unit of our University Hospitals.

Study period: March 2015 to March 2018. Source of data: Patients admitted with clinical diagnosis of acute cholecystitis, biliary colic, mucocele or pyocele of gall bladder in patients with cardiopulmonary diseases.

Sample size: A total of 470 patients with a clinical diagnosis of acute cholecystitis, biliary colic, mucocele or pyocele of gall bladder in patients with cardiopulmonary diseases.

Sampling method: simple random sample with a balance Method of sample size calculation: Sample size calculated to be 235 at each group based on operation time difference between conventional and funds first group from previous paper with 80% power of study and 95% confidence interval. Ref Cengiz, Y., Lund, M., Jänes, A. et al. Fundus first as the standard technique for laparoscopic cholecystectomy. Sci Rep 9, 18736 (2019). https://doi.org/10.1038/s41598-019-55401-6

Patient selection criteria:

  1. Inclusion criteria:
  2. Age: any age.
  3. Sex: Male and Non pregnant female.
  4. Patients with cardiopulmonary diseases.
  5. Patients who diagnose acute cholecystitis not improving on medical treatment for 48 hours.
  6. Patients with biliary colic, mucocele of gall bladder and pyocele of gall bladder.
  7. American Society of Anesthesiologist's (ASA) score: grade I, II, III.

Exclusion criteria:

  1. ASA grade IV
  2. Patients refuse surgery.
  3. Documented Liver disease.
  4. Previous percutaneous cholecystostomy
  5. Cases not tolerated CO2 insufflation from the start.

Preoperative work up: All patients included in the study underwent:

  1. Full clinical examination: pain in right hypochondrium radiated to right shoulder, local examination revealed tenderness in right hypochondrium or mass and fever.
  2. Ultrasonography: thick edematous wall of gall bladder distended gall bladder or stone impacted in gall bladder neck.
  3. Blood investigations :leukocytosis
  4. Liver Function Tests.
  5. Chest x-ray
  6. ECG and cardiac Echocardiography.

Patients are divided into 2 groups:

Group A (n = 235): patients underwent laparoscopic cholecystectomy with low pressure pneumoperitoneum and initial fundus first cholecystectomy followed by dissection of Calot triangle.

Group B (n=235): patients underwent laparoscopic cholecystectomy with low pressure pneumoperitoneum and Calot first cholecystectomy from the start.

Efforts to decrease bias in the study:

  1. For pretrial bias: Good Define objectives. Risk and outcome .Select patients on probability sample with adequate sample size. Define confound factors and avoid it
  2. To avoid during trial bias: Standardize reaction and management of patients blindly-Objective data use rather than subjective-Good handling of data- plan designed for drop out
  3. To avoid after trial bias: Suitable statistical analysis used-Good and carefully interpretation-Control of confound

Methods:

The patients were given general anesthesia. Nasogastric and urinary bladder catheters were inserted to ensure the stomach and bladder were empty. Through the periumbilical incision, A Hasson technique was used and a trocar is introduced to the abdomen under vision. Pneumoperitoneum was created 8-10 mm Hg. The camera was introduced and the abdominal cavity inspected. A 10 mm trocar was placed at the level of epigastrium 5 cm below xiphoid process. A third 5 mm trocar was placed just below the right subcostal margin. 4th trocar is inserted at the level of umbilicus at anterior axillary line.

Fundus first approach initial approach: we start dissection of the peritoneum at the side of gall bladder and perform dissection in inverted U shaped incision in the peritoneum covering the side and fundus of gall bladder then the gall bladder is dissected free from gall bladder bed .then the fundus of gall bladder is retracted towards easily to the right shoulder and start exposure and dissection of the Calot triangle .in this way, dissection of Calot triangle became very easy. Sometimes aspiration of the gall bladder contents helped us to grasp the fundus.

Calot triangle first dissection: we started dissection at gall bladder neck. Adhesions to omentum, colon, duodenum or stomach are pulled away by blunt and diathermy dissection. Dissection continued very close to gall bladder wall. Identification of Calot triangle helped us to recognize the anatomy. Cystic duct and cystic artery are dissected free and clipped and divided. Then the gall bladder is dissected free from the liver. The gallbladder bed was inspected for hemostasis which was achieved by coagulation. The gallbladder was removed from the abdomen through the epigastric port. Irrigation and suction of the bed was performed and a drain is put in gall bladder bed. Under vision, all ports were removed. The umbilical incision was closed in layers with Vicryl No 1 and subcuticular with prolene three zero.

Outcome measures:

Primary outcomes

  1. Mortality (90-day mortality and mortality at maximal follow-up).
  2. Postoperative complications: early (hemorrhage, bile leak, wound infection) and late complications (biliary stricture)
  3. Port site hernia Secondary outcomes
  4. Conversion to open cholecystectomy.
  5. Total hospital stay.
  6. Intra-operative findings (duration of operation, intra-operative bleeding and iatrogenic injuries)
  7. Return to work.
Being tested
start with fundus, calot first dissection
Keywords
laparoscopy, cholecystectomy
Medical subject headings
Gallbladder Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • start with fundusProcedure or surgery

    fundus first dissection then complete cholecystectomy as usual

  • calot first dissectionProcedure or surgery

    start dissection by calot approach

Study groups in NCT04368611
Study groupRoleWhat they receive
fundus first cholecystectomyActive comparatorstart with fundus dissection then complete the dissection
Receives: Procedure: start with fundus
Calot first dissectionActive comparatorstart and complete the dissection by dissection of Calot triangle
Receives: Procedure: calot first dissection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. duration of operation in minutes

    time taken to complete the surgery in minutes

    Measured: 2 hours

Secondary outcomes (1)
  1. stricture of the biliary tract

    stenosed bile duct that induce jaundice on laboratory investigations

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2020
  2. Study start1 Mar 2015
  3. Primary completion1 Mar 2018
  4. Study completion1 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04368611
Sponsor's protocol ID
lap cholecystectomy 1
Status last verified
Apr 2020
First submitted
27 Apr 2020
Last updated
30 Apr 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing start with fundus and calot first dissection in people with Laparoscopy and Biliary Disease, run by Zagazig University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

duration of operation in minutes (time frame: 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in